Overall, these data indicate that the anti-proliferative effect of MDX-124 is associated with ANXA1 expression, as cell lines responsive to MDX-124 treatment all expressed ANXA1, whereas a non-expressing lung cancer cell line (COR-L23) exhibited no response to MDX-124. The gene discussed is ANXA1; the disease is lung carcinoma.